NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 64 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2020-03-10
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2013-09-28 was 404.05K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2013-06-29 was 533.07K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2013-03-30 was 781.24K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2019 was 64.00 shares, a 75.94% decline from fiscal 2018.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2018 was 266.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month |
|---|---|---|---|---|
| 2019-12-31 | 64.00 shares 10-K · filed 2020-03-10 | |||
| 2018-12-31 | 266.00 shares 10-K · filed 2020-03-10 | |||
| 2013-09-28 | 404.05K shares 10-Q · filed 2013-11-21 | 937.11K shares derived: sum of 2 quarters · filed 2013-12-05 | 1.72M shares 10-Q · filed 2013-11-21 | |
| 2013-06-29 | 533.07K shares 10-Q/A · filed 2013-12-05 | 1.31M shares 10-Q/A · filed 2013-12-05 | ||
| 2013-03-30 | 781.24K shares 10-Q/A · filed 2013-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |